Insider Transactions in Q2 2023 at Alnylam Pharmaceuticals, Inc. (ALNY)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 28
2023
|
Pushkal Garg CMO & EVP Dev & Med Affairs |
SELL
Open market or private sale
|
Direct |
2,455
-7.01%
|
$486,090
$198.55 P/Share
|
|
Apr 27
2023
|
Jeffrey V. Poulton EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
977
-1.58%
|
$189,538
$194.96 P/Share
|
|
Apr 27
2023
|
Pushkal Garg CMO & EVP Dev & Med Affairs |
SELL
Open market or private sale
|
Direct |
1,839
-4.6%
|
$356,766
$194.96 P/Share
|
|
Apr 27
2023
|
Akshay Vaishnaw President |
SELL
Open market or private sale
|
Direct |
2,392
-2.46%
|
$464,048
$194.96 P/Share
|
|
Apr 27
2023
|
Tolga Tanguler EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,476
-10.86%
|
$286,344
$194.96 P/Share
|
|
Apr 27
2023
|
Yvonne Greenstreet Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
7,615
-4.32%
|
$1,477,310
$194.96 P/Share
|
|
Apr 26
2023
|
Jeffrey V. Poulton EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,277
+20.53%
|
-
|
|
Apr 26
2023
|
Pushkal Garg CMO & EVP Dev & Med Affairs |
BUY
Grant, award, or other acquisition
|
Direct |
4,294
+33.2%
|
-
|
|
Apr 26
2023
|
Akshay Vaishnaw President |
BUY
Grant, award, or other acquisition
|
Direct |
5,312
+20.75%
|
-
|
|
Apr 26
2023
|
Tolga Tanguler EVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,277
+50.0%
|
-
|
|
Apr 26
2023
|
Yvonne Greenstreet Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,952
+30.88%
|
-
|
|
Apr 06
2023
|
Indrani Lall Franchini EVP, CLO & Secretary |
SELL
Open market or private sale
|
Direct |
3,500
-100.0%
|
$735,000
$210.0 P/Share
|